Skip to main content
. 2018 Feb 20;163(2):440–453. doi: 10.1093/toxsci/kfy041

Figure 4.

Figure 4.

Effect of PCB126 on serum and hepatic glucose levels. Glucose levels in serum (A) and liver extracts (B) of PCB126-treated (5 µmol/kg) rats (gray bars, n = 4–7 animals/group) were compared with the vehicle control (black bars, n = 6–8 animals/group). Two-way ANOVA analysis of PCB126 treatment × fasting showed a significant interaction (p = .0139) (2-way ANOVA-Tukey; * represents p < .05 and α represents p < .05 compared with fed- and vehicle-treated animals).